KOREA WHO

Yoon Tae-young is the CEO of Oscotec.

He was born on October 29, 1962.

He graduated from Seoul National University with a degree in chemistry, earned his master’s degree in chemistry from the same university, and later received his Ph.D. in chemistry from Yale University in the United States.

After completing his postdoctoral research at the California Institute of Technology (Caltech), he spent 16 years devoted to research at global pharmaceutical companies such as Neurogen and Novartis.

He later served as Head of the Innovative Drug Research Institute at Dong-A ST and Dong-A Socio Holdings before being appointed CEO of Oscotec in 2020.

Together with CEO Lee Sang-hyun, who oversees overall management, he leads Oscotec under a co-CEO system.

He has been recognized for his drug development capabilities after developing the lung cancer treatment Lazertinib and transferring its technology to Yuhan Corporation and Janssen. He is now focusing on developing an Alzheimer’s treatment to create the “second Lazertinib.”

#Oscotec #YoonTaeyoung #biotechnology #newdrug #Lazertinib #Yuhan #Janssen #Alzheimers #pharma #R&D